Medical Device Mass Tort TV Ad Trends - Q4 2024 - 1.31.25
Excepting the year's previous quarter, fourth-quarter spending on medical device injury claim ads decreased, totaling over $966,000 for approximately 6,000 ads nationwide. Notably, spinal cord stimulators emerged as a new mass tort ad target, with 111 ads aired.
Medical Device Mass Tort TV Ad Trends - Q3 2024 - 10.31.24
Excepting the year’s first quarter, third quarter spending exceeded all prior quarters since the second quarter of 2023. Estimated spending on these ads jumped by over $280,000 or 25%.
Implanted ports remained the top medical device mass tort ad target in the third quarter as in the second and is the top medical device target of the year to date.
Medical Device Mass Tort TV Ad Trends - Q2 2024 - 8.1.24
Medical Device Mass Tort TV Ad Trends - Q1 2024 - 4.30.24
AdvaMed Submits Letter to House Committee on Oversight and Accountability Concerning Third-Party Litigation Funding
- Government & Legislative Affairs
- Legal
WASHINGTON – Today, AdvaMed, the Medtech Association, submitted a letter to the House Committee on Oversight and Accountability regarding the Committee’s consideration of an issue that threatens to undermine the foundations of our health care system: outside financing that generates mass tort litigation over important, beneficial medical devices.
Medical Device Mass Tort TV Ad Trends - Q2 2023 - 7.31.23
Estimated spending on medical device claims solicitation advertising increased dramatically from the first to the second quarter, when $4.25 million was spent to air these ads during television programming throughout the nation. • In June alone, spending on these ads skyrocketed from the prior month to more than $3 million—the highest in a month since October 2019. • More than 12,000 television advertisements soliciting medical device injury claims aired in the second quarter of 2023—roughly the same number that aired in the first quarter.
Medical Device Mass Tort TV Ad Trends - Q1 2023 - ET - 5.2.23
More than 12,000 television advertisements soliciting medical device injury claims aired in the first quarter of the year, but this was less than half that of the previous quarter. In the first quarter from January through March, over $1.3 million was spent to air these litigation-related ads and this was just over half what was spent on these ads during the October through December period. Monthly first-quarter advertising peaked in January by measure of both ad count and estimated ad spending when nearly 4,400 ads aired at a cost of about $610,000.
Third-Party Litigation Financing: Market Characteristics, Data, and Trends
What GAO Found. Third-party litigation financing is an arrangement where a funder that is not a party to a lawsuit agrees to provide funding to a litigant (typically a plaintiff) or law firm in exchange for an interest in the potential recovery in a lawsuit (see figure).